Canada readies efforts to curtail drug traffic

Canadian officials say they're preparing to unveil new proposals that would put the brakes on the sale of drugs south of the border. One possible change would be to prevent Canadian doctors from signing a prescription for a patient they hadn't seen. That would be a big win for US drug companies, which have been lobbying hard to kill off the flow of less expensive Canadian meds to US customers.

- read this story from the Chicago Tribune

Suggested Articles

The public financing will enable Monopar to start a phase 3 trial of a prophylactic treatment for a side effect of chemoradiotherapy. 

The dispute centers on whether Asa Abeliovich used Alector’s confidential information in connection with his work for Prevail Therapeutics.

GSK poaches Merck KGaA's Martinez-Davis to helm pharma stateside; Bulto named Novartis U.S. pharma head; Allergan's Saunders set for huge parachute.